Scholar Rock Holding Corp. (SRRK)
45.43
+3.13
(+7.40%)
USD |
NASDAQ |
Mar 25, 16:00
45.30
-0.13
(-0.29%)
Pre-Market: 09:23
Scholar Rock Cash from Investing (Quarterly) : 38.97M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Krystal Biotech, Inc. | 11.16M |
| Stoke Therapeutics, Inc. | -61.06M |
| Zymeworks, Inc. | 5.10M |
| Amylyx Pharmaceuticals, Inc. | 29.47M |
| ACADIA Pharmaceuticals, Inc. | -55.87M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -75.50M |
| Cash from Financing (Quarterly) | 73.29M |
| Free Cash Flow | -300.64M |
| Free Cash Flow Per Share (Quarterly) | -0.7327 |
| Free Cash Flow to Equity (Quarterly) | -74.37M |
| Free Cash Flow to Firm (Quarterly) | -72.99M |
| Free Cash Flow Yield | -6.00% |